复发缓解型多发性硬化患者疾病早期即出现全脑体积和丘脑体积加速丢失
本研究基于纵向MRI数据库,对比195名健康个体与256例复发缓解型多发性硬化(PwRRMS)患者的年度全脑体积丢失(BVL/year)和年度丘脑体积丢失(ThalaVL/year),采用雅可比积分法计算并经线性回归分解为MS相关与年龄相关成分。结果显示,病程≤6年的早期患者MS相关BVL/year和ThalaVL/year均显著高于病程>6年的后期患者,提示MS相关脑体积丢失在疾病早期加速、后期减缓。
要点
- 早期(病程≤6年)PwRRMS的MS相关BVL/year为-0.21%,显著高于后期(>6年)的-0.06%(p=0.007)。
- 早期PwRRMS的MS相关ThalaVL/year为-0.39%,后期为-0.00%(p<0.0001),组间差异更明显。
- MS相关脑体积和丘脑体积丢失在疾病早期加速、后期减缓,或可解释早期干预改善预后的现象。
核心结论
- 在PwRRMS中,MS相关的BVL/year和ThalaVL/year在疾病早期加速、在后期减缓。
- 这一发现可能解释为何早期干预常使MS患者获得更好结局。
研究设计与样本
- 纵向数据库分析,纳入195名健康个体(年龄范围22.8-63.7岁)和256例PwRRMS患者(年龄范围20.1-60.8岁)的纵向MRI数据。
- 采用雅可比积分法计算健康个体及所有MS患者的BVL/year和ThalaVL/year。
- 对健康个体用线性回归计算年龄与BVL/year、ThalaVL/year的关系,再将每例PwRRMS的BVL/year和ThalaVL/year分解为MS相关成分与年龄相关成分。
- 将PwRRMS按病程分为早期组(病程≤6年,n=135)和后期组(病程>6年,n=121),用t检验比较组间差异。
诊断标准与关键数值
- 早期组(病程≤6年,n=135)MS相关BVL/year为-0.21%,后期组(n=121)为-0.06%,组间差异p=0.007。
- 早期组MS相关ThalaVL/year为-0.39%,后期组为-0.00%,组间差异p<0.0001。
- 分组阈值:病程≤6年为早期-phase RRMS,病程>6年为later-phase RRMS。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: The aim of this study was to investigate the dynamics of annual whole brain volume loss (BVL/year) and annual thalamic volume loss (ThalaVL/year) in patients with relapsing-remitting multiple sclerosis (PwRRMS) during the course of the disease.
METHODS: A longitudinal database of magnetic resonance imaging (MRI) scans of 195 healthy individuals (age range, 22.8-63.7 years) and longitudinal MRI data of 256 PwRRMS (age range, 20.1-60.8 years) were analyzed and compared. BVL/year and ThalaVL/year were computed for healthy individuals as well as for all patients with MS using a Jacobian integration approach. A linear regression was used to compute the relationship between age and BVL/year and ThalaVL/year for healthy individuals. The linear regression was then used to decompose the BVL/year and ThalaVL/year into a multiple sclerosis (MS)-related and an age-related component for each PwRRMS. PwRRMS were dichotomized into early-phase RRMS (disease duration ≤ 6 years) and later-phase RRMS (disease duration > 6 years), and a t-test was performed to test for differences between these groups.
RESULTS: The 135 early-phase patients (disease duration, ≤ 6 years) had statistically significantly higher MS-related BVL/year than the later-phase patients (n = 121) (- 0.21% vs. - 0.06%, p = 0.007). For MS-related ThalaVL/year, the difference between the groups was even more pronounced (- 0.39% vs. - 0.00%, p < 0.0001).
CONCLUSIONS: Our results indicate that in PwRRMS, the MS-related components of BVL/year and ThalaVL/year are accelerated in early phases and slowdown in later phases of the disease. This might explain why early intervention often leads to improved outcomes in patients with MS.
引用
- Opfer R, Schwab M, Bangoura S, et al. Patients with relapsing-remitting multiple sclerosis show accelerated whole brain volume and thalamic volume loss early in disease. Neuroradiology. 2024. PMID: 39607558. doi:10.1007/s00234-024-03516-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。